NeuroMetrix, Inc. (NURO)
May 1, 2025 - NURO was delisted (reason: acquired by ECOR)
4.580
0.00 (0.00%)
Inactive · Last trade price
on May 1, 2025
Company Description
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing and sale of medical devices.
Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; and Quell, a wearable device for symptomatic relief and management of chronic pain.
The company offers its products to managed endocrinologists, podiatrists, primary care physicians, and other clinicians at the point-of care to objectively detect, stage, and monitor peripheral neuropathies.
NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
NeuroMetrix, Inc.
| Country | United States |
| Founded | 1996 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 13 |
| CEO | Shai Gozani |
Contact Details
Address: 4B Gill Street Woburn, Massachusetts 01801 United States | |
| Phone | 781 890 9989 |
| Website | neurometrix.com |
Stock Details
| Ticker Symbol | NURO |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001289850 |
| CUSIP Number | 641255807 |
| ISIN Number | US6412558800 |
| Employer ID | 04-3308180 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Shai N. Gozani M.D., Ph.D. | Founder, Chairman, Chief Executive Officer, President and Secretary |
| Thomas T. Higgins | Senior Vice President, Chief Financial Officer and Treasurer |
| Dr. Xuan Kong Ph.D. | Chief Data Scientist |
| Susan M. Bell R.N. | Senior Vice President of Population Health and Value Based Care |